Evaluation of in vitro degradation of PCL scaffolds fabricated via BioExtrusion - Part 2: Influence of pore size and geometry The present study is to accurately investigate the influence of design parameters, such as filament distance (FD) and lay-down pattern, on the degradation behaviour and kinetics of PCL scaffolds, obtained via BioExtrusion

被引:36
作者
Domingos, M. [1 ]
Chiellini, F. [2 ]
Cometa, S. [2 ]
De Giglio, E. [3 ]
Grillo-Fernandes, E. [2 ]
Bartolo, P. [1 ]
Chiellini, E. [2 ]
机构
[1] Polytech Inst Leiria IPL, Ctr Rapid & Sustainable Product Dev, Leiria, Portugal
[2] Univ Pisa, Dept Chem & Ind Chem, Lab Bioact Polymer Mat Biomed & Environm Applicat, Pisa, Italy
[3] Univ Bari, Dept Chem, Bari, Italy
关键词
biomanufacturing; biomaterials; scaffolds; tissue engineering; extrusion;
D O I
10.1080/17452759.2011.605839
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
The in vivo degradation processes by which scaffolds degrade and are replaced by neo-tissue are complex and may be influenced by many factors, including environmental conditions, material properties, porosity and 3D architecture. The present study is focused on the influence of design parameters, filament distance (FD) and lay-down pattern, on the degradation kinetics of Polycaprolactone (PCL) scaffolds obtained via BioExtrusion. Through the variation of design parameters it was possible to obtain two groups of scaffolds with distinct pore geometry and size. The in vitro degradation was performed in simulated body fluid (SBF) and in phosphate buffer solution (PBS) for six months. Our results highlight a more complex degradation pattern of the scaffolds in SBF than in PBS, probably related to a mineral deposition. Significant statistical differences in weight loss values at month 6, allowed us to conclude that degradation kinetics of PCL scaffolds is strongly influenced by the pore size.
引用
收藏
页码:157 / 165
页数:9
相关论文
共 21 条
[1]  
Almeida H.A., 2010, Portuguese Patent, Patent No. 104247
[2]  
Bredt JF, 1998, US Patent, Patent No. 5807437
[3]  
Chu T. M. G., 2006, SCAFFOLDING TISSUE E, P139
[4]   Evaluation of in vitro degradation of PCL scaffolds fabricated via BioExtrusion. Part 1: Influence of the degradation environment [J].
Domingos, M. ;
Chiellini, F. ;
Cometa, S. ;
De Giglio, E. ;
Grillo-Fernandes, E. ;
Bartolo, P. ;
Chiellini, E. .
VIRTUAL AND PHYSICAL PROTOTYPING, 2010, 5 (02) :65-73
[5]  
Domingos M, 2009, INNOVATIVE DEV DESIG, P67
[6]   Polycaprolactone Scaffolds Fabricated via Bioextrusion for Tissue Engineering Applications [J].
Domingos, Marco ;
Dinucci, Dinuccio ;
Cometa, Stefania ;
Alderighi, Michele ;
Bartolo, Paulo Jorge ;
Chiellini, Federica .
INTERNATIONAL JOURNAL OF BIOMATERIALS, 2009, 2009
[7]  
Gloria A, 2009, J APPL BIOMATER BIOM, V7, P141
[8]  
Hull CW., 1990, Method for production of three-dimensional objects by stereolithography, Patent No. [US Patent 4929402, 4929402, US 4929402 A]
[9]  
Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
[10]  
Landers R, 2000, MACROMOL MATER ENG, V282, P17, DOI 10.1002/1439-2054(20001001)282:1<17::AID-MAME17>3.0.CO